Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.

Journal of gastroenterology and hepatology - 1 Jun 2014

Jiang Yingjie, Nie Yuqiang, Li Yuyuan, Zhang Long

Abstract excerpt

BACKGROUND AND AIM: The endocannabinoid system is involved in the pathophysiology of irritable bowel syndrome (IBS). Here, we investigated whether genetic variants of the cannabinoid type 1 receptor (CNR1) and fatty acid amide hydrolase (FAAH) are associated with the pathogenesis of IBS. METHODS: In total, 292 patients with IBS and 298 healthy controls were enrolled. Polymerase chain reaction (PCR) and DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases
Share to Asian People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Genetic Predisposition to Disease

Share to Irritable Bowel Syndrome

Share to Polymorphism, Single Nucleotide

Share to Receptor, Cannabinoid, CB1

Share to Trinucleotide Repeats

Source

Identifiers

PMID: 24444427
DOI: 10.1111/jgh.12513

Genes

CNR1
FAAH

Variants

rs324420

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome.PMID 24444427Read ↗

Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study.Semantic proximity Read ↗

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.Semantic proximity Read ↗

Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits.Semantic proximity Read ↗

Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.Semantic proximity Read ↗

The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.Semantic proximity Read ↗

The role of fatty acid hydrolase gene variants in inflammatory bowel disease.Semantic proximity Read ↗

Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.Semantic proximity Read ↗

Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases.Semantic proximity Read ↗

Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.Semantic proximity Read ↗

Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome.Semantic proximity Read ↗

Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity.Semantic proximity Read ↗

No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.